Abstract:tologically a low-grade angiosarcoma. There are less than 200 cases of tumorous PASH and less than 20 of diffuse PASH reported so far. Here we present a case report of huge diffuse PASH, that is, to our knowledge, the first in a pregnant woman.
“…These interactions could increase the level of progesterone that could stimulate PASH growth. A hormonal etiology is also supported by the higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills) [16], in 24% to 47% of men with gynecomastia [17] and by reported case of PASH in a transgender male during hormone therapy [18] or during pregnancy [19]. PASH affects pre-menopausal women or menopausal women in hormone replacement therapy (HRT).…”
Objective: Unknown ethiology Background: Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign breast lesion. Case Report: PASH is reported in a young female in treatment for neurological diseases with multi-drug therapy (clonazepam, valproate and risperidone). Her menstrual cycles are irregular, and she reached menarche very late. Conclusions: The higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills), in 24% to 47% of men with gynecomastia and during pregnancy supports a hormonal etiology; the interaction between clonazepam, valproate, risperidone and progesterone could increase the level of progesterone that could stimulate PASH growth.
“…These interactions could increase the level of progesterone that could stimulate PASH growth. A hormonal etiology is also supported by the higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills) [16], in 24% to 47% of men with gynecomastia [17] and by reported case of PASH in a transgender male during hormone therapy [18] or during pregnancy [19]. PASH affects pre-menopausal women or menopausal women in hormone replacement therapy (HRT).…”
Objective: Unknown ethiology Background: Pseudoangiomatous stromal hyperplasia (PASH) is an uncommon benign breast lesion. Case Report: PASH is reported in a young female in treatment for neurological diseases with multi-drug therapy (clonazepam, valproate and risperidone). Her menstrual cycles are irregular, and she reached menarche very late. Conclusions: The higher PASH prevalence in premenopausal woman (the majority of whom are actively taking oral contraceptive pills), in 24% to 47% of men with gynecomastia and during pregnancy supports a hormonal etiology; the interaction between clonazepam, valproate, risperidone and progesterone could increase the level of progesterone that could stimulate PASH growth.
“…10 In support of this theory, there have been a few case reports of rapid bilateral breast enlargement associated with PASH during pregnancies, most likely in response to rising hormone levels. 11,12 The histologic features of PASH has also been shown to resemble those of intralobular stroma during the luteal phase of the menstrual cycle, when progesterone secretion is high. 13 Despite its hyperplastic nature, the condition is not associated with increased risk of breast malignancy.…”
“…Bilateral diffuse multiple tumors leading to massive bilateral breast enlargement are rare. Other reports have been published presenting patients with bilateral gigantomastia due to PASH [5][6][7][8][9], all reporting bilateral breast enlargement, with palpable masses in some cases. However, Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Until today, no recurrence has been observed during follow-up. In the other cases presenting patients with bilateral gigantomastia due to PASH, mastectomies were performed, except for two where in one patient a breast reduction was performed and in the other one the lesions were observed [5][6][7][8][9]. No recurrence was reported.…”
A 15-year-old female patient presented to our clinic with rapidly-growing breasts, causing her back and neck pain, mastalgia, and unwanted attention at school. Clinical evaluation showed bilateral enlarged breasts with multiple palpable tumors. Her height and body weight were 1.76 m and 54 kg, respectively. Both ultrasound and magnetic resonance imaging (MRI) were conducted. Histological biopsies showed pseudoangiomatous stroma hyperplasia (PASH). Bilateral diffuse multiple tumors leading to massive bilateral breast enlargement are rare, especially in pediatric patients. To the best of our knowledge, all previous reported cases were patients of 29 years old or older. We present the evaluation and treatment in a rare case of multiple PASH causing bilateral gigantomastia in an adolescent patient. Level of evidence: Level V, therapeutic study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.